M L 4 (Levothyroxine 25 mcg (0.025 mg))
Pill imprint M L 4 has been identified as Levothyroxine sodium 25 mcg (0.025 mg).
Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; tsh suppression; thyroid suppression test; myxedema coma (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 25 mcg (0.025 mg)
- 9.00 mm
- Prescription only
sodium lauryl sulfate
FD&C Yellow No. 6
|NDC Code||Manufacturer / Repackager|
|51079-0444||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about levothyroxine
- Levothyroxine capsules
- Levothyroxine solution
- Levothyroxine (Advanced Reading)
- Levothyroxine Injection (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.